Cargando…
Visceral Obesity in Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Body mass index may be an inappropriate metric for obesity in lung cancer as its use obscures the harm that obesity causes, which is noticeable when obesity is instead measured as visceral adiposity. Radiological assessment of visceral adiposity is practicable in lung cancer as patie...
Autores principales: | Nitsche, Lindsay, Vedire, Yeshwanth, Kannisto, Eric, Wang, Xiaolong, Seager, Robert J., Pabla, Sarabjot, Patnaik, Santosh K., Yendamuri, Sai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315749/ https://www.ncbi.nlm.nih.gov/pubmed/35884508 http://dx.doi.org/10.3390/cancers14143450 |
Ejemplares similares
-
Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC
por: Patnaik, Santosh K., et al.
Publicado: (2021) -
Obesity and lung cancer—a narrative review
por: Vedire, Yeshwanth, et al.
Publicado: (2023) -
Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer
por: Vedire, Yeshwanth Reddy, et al.
Publicado: (2023) -
Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer
por: Vedire, Yeshwanth, et al.
Publicado: (2023) -
Whole blood microRNA expression may not be useful for screening non-small cell lung cancer
por: Patnaik, Santosh K., et al.
Publicado: (2017)